Poster 16
- Jun 19, 2023
- 1 min read
Lebrikizumab Provides Clinically Meaningful Response in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: ADhope1 Study Primary Results
Diamant Thaçi, Alan Irvine, Christian Vestergaard, Christine Bangert, Jan Gutermuth, Helena Agell, Júlia Valls Bancells, Victor Sapena, Ruth Coll, Marjolein de Bruin-Weller


